The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blazar, B. R.
Right arrow Articles by Vallera, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blazar, B. R.
Right arrow Articles by Vallera, D. A.

The Journal of Immunology, Vol 157, Issue 8 3250-3259, Copyright © 1996 by American Association of Immunologists


ARTICLES

Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells

BR Blazar, AH Sharpe, PA Taylor, A Panoskaltsis-Mortari, GS Gray, R Korngold and DA Vallera
Department of Pediatrics, University of Minnesota, Minneapolis 55455, USA.

Efficient T cell proliferation requires costimulation via CD28/B7 or other pathways. Graft-vs-host disease (GVHD) is caused by activated donor T cells. We have found that the infusion of anti-B7.1 (CD80) + anti-B7.2 (CD86) mAb is effective in eliminating GVHD lethality induced by either CD8+ or CD4+ T cells. Donor CD4+ and CD8+ T cell expansion was inhibited by almost 100-fold as measured by enumerating thoracic duct lymphocytes (TDL) obtained early post-transplant. TDL retained anti-host responsiveness indicating that not all T cells were anergic. Although anti-CD80 or anti-CD86 mAb individually were ineffective in preventing CD8+ T cell GVHD lethality, each mAb was partially effective in CD4+ T cell-mediated GVHD. Because CD80 expression was found to be up-regulated on donor CD4+ TDL post-transplant, the GVHD capacity of donor CD4+ T cells deficient in CD80 was tested and found to be reduced similarly to that seen with anti-CD80 mAb. These studies demonstrate that anti-CD80 + anti-CD86 mAb infusion is effective in preventing GVHD lethality by inhibiting donor CD4+ or CD8+ T cell expansion and provide the first evidence that CD80 expression on donor T cells is critical for optimal GVHD lethality.


This article has been cited by other articles:


Home page
J. Immunol.Home page
B. Verbinnen, A. D. Billiau, J. Vermeiren, G. Galicia, D. M. A. Bullens, L. Boon, P. Cadot, G. Hens, C. Dewolf-Peeters, S. W. Van Gool, et al.
Contribution of Regulatory T Cells and Effector T Cell Deletion in Tolerance Induction by Costimulation Blockadel
J. Immunol., July 15, 2008; 181(2): 1034 - 1042.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Hurchla, J. R. Sedy, and K. M. Murphy
Unexpected Role of B and T Lymphocyte Attenuator in Sustaining Cell Survival during Chronic Allostimulation
J. Immunol., May 15, 2007; 178(10): 6073 - 6082.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nierkens, M. Aalbers, M. Bol, R. Bleumink, P. van Kooten, L. Boon, and R. Pieters
Differential Requirement for CD28/CTLA-4-CD80/CD86 Interactions in Drug-Induced Type 1 and Type 2 Immune Responses to Trinitrophenyl-Ovalbumin
J. Immunol., September 15, 2005; 175(6): 3707 - 3714.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. E. Anderson, J. M. McNiff, D. Jain, B. R. Blazar, W. D. Shlomchik, and M. J. Shlomchik
Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ
Blood, March 1, 2005; 105(5): 2227 - 2234.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
T. Iwasaki
Recent Advances in the Treatment of Graft-Versus-Host Disease
Clin. Med. Res., November 1, 2004; 2(4): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. E. Anderson, J. M. McNiff, C. Matte, I. Athanasiadis, W. D. Shlomchik, and M. J. Shlomchik
Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease
Blood, September 1, 2004; 104(5): 1565 - 1573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Panoskaltsis-Mortari, J. R. Hermanson, E. Taras, O. D. Wangensteen, I. F. Charo, B. J. Rollins, and B. R. Blazar
Post-BMT lung injury occurs independently of the expression of CCL2 or its receptor, CCR2, on host cells
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L284 - L292.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Taylor, C. J. Lees, S. Fournier, J. P. Allison, A. H. Sharpe, and B. R. Blazar
B7 Expression on T Cells Down-Regulates Immune Responses through CTLA-4 Ligation via R-T Interactions
J. Immunol., January 1, 2004; 172(1): 34 - 39.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Panoskaltsis-Mortari, J. R. Hermanson, E. Taras, O. D. Wangensteen, J. S. Serody, and B. R. Blazar
Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1alpha (CCL3) after allogeneic BMT in mice
Blood, May 1, 2003; 101(9): 3714 - 3721.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Mukherjee, P. K. Maiti, and D. Nandi
Role of CD80, CD86, and CTLA4 on mouse CD4+ T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin
J. Leukoc. Biol., November 1, 2002; 72(5): 921 - 931.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Liu, J. G. Heuer, S. Na, E. Galbreath, T. Zhang, D. D. Yang, A. Glasebrook, and H. Y. Song
Accelerated Onset and Increased Severity of Acute Graft-Versus-Host Disease Following Adoptive Transfer of DR6-Deficient T Cells
J. Immunol., October 1, 2002; 169(7): 3993 - 3998.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Lang, P. Nguyen, R. Peach, W. C. Gause, and C. S. Via
In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function
J. Immunol., April 15, 2002; 168(8): 3786 - 3792.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Liu, B. E. Anderson, M. E. Robert, J. M. McNiff, S. G. Emerson, W. D. Shlomchik, and M. J. Shlomchik
Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease: a model system for the reversal of disease
Blood, December 1, 2001; 98(12): 3367 - 3375.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. A. Taylor, C. J. Lees, H. Waldmann, R. J. Noelle, and B. R. Blazar
Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions
Blood, July 15, 2001; 98(2): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Blazar, B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon, and P. A. Taylor
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients
J. Immunol., March 1, 2001; 166(5): 3174 - 3183.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Lu, S. Sakamaki, H. Kuroda, T. Kusakabe, Y. Konuma, T. Akiyama, A. Fujimi, N. Takemoto, K. Nishiie, T. Matsunaga, et al.
Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603
Blood, February 15, 2001; 97(4): 1123 - 1130.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Panoskaltsis-Mortari, P. A. Taylor, J. S. Rubin, A. Uren, L. A. Welniak, W. J. Murphy, C. L. Farrell, D. L. Lacey, and B. R. Blazar
Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury
Blood, December 15, 2000; 96(13): 4350 - 4356.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Blazar, C. J. Lees, P. J. Martin, R. J. Noelle, B. Kwon, W. Murphy, and P. A. Taylor
Host T Cells Resist Graft-Versus-Host Disease Mediated by Donor Leukocyte Infusions
J. Immunol., November 1, 2000; 165(9): 4901 - 4909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Panoskaltsis-Mortari, D. H. Ingbar, P. Jung, I. Y. Haddad, P. B. Bitterman, O. D. Wangensteen, C. L. Farrell, D. L. Lacey, and B. R. Blazar
KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT
Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L988 - L999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X.-Z. Yu, S. J. Bidwell, P. J. Martin, and C. Anasetti
CD28-Specific Antibody Prevents Graft-Versus-Host Disease in Mice
J. Immunol., May 1, 2000; 164(9): 4564 - 4568.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Newell, G. He, Z. Guo, O. Kim, G. L. Szot, I. Rulifson, P. Zhou, J. Hart, J. R. Thistlethwaite, and J. A. Bluestone
Cutting Edge: Blockade of the CD28/B7 Costimulatory Pathway Inhibits Intestinal Allograft Rejection Mediated by CD4+ But Not CD8+ T Cells
J. Immunol., September 1, 1999; 163(5): 2358 - 2362.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
I. Y. Haddad, A. Panoskaltsis-Mortari, D. H. Ingbar, S. Yang, C. E. Milla, and B. R. Blazar
High Levels of Peroxynitrite Are Generated in the Lungs of Irradiated Mice Given Cyclophosphamide and Allogeneic T Cells . A Potential Mechanism of Injury after Marrow Transplantation
Am. J. Respir. Cell Mol. Biol., June 1, 1999; 20(6): 1125 - 1135.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
B. R. Blazar, P. A. Taylor, A. Panoskaltsis-Mortari, A. H. Sharpe, and D. A. Vallera
Opposing Roles of CD28:B7 and CTLA-4:B7 Pathways in Regulating In Vivo Alloresponses in Murine Recipients of MHC Disparate T Cells
J. Immunol., June 1, 1999; 162(11): 6368 - 6377.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. S. Serody, D. N. Cook, S. L. Kirby, E. Reap, T. C. Shea, and J. A. Frelinger
Murine T Lymphocytes Incapable of Producing Macrophage Inhibitory Protein-1alpha Are Impaired in Causing Graft-Versus-Host Disease Across a Class I But Not Class II Major Histocompatibility Complex Barrier
Blood, January 1, 1999; 93(1): 43 - 50.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X.-Z. Yu, P. J. Martin, and C. Anasetti
Role of CD28 in Acute Graft-Versus-Host Disease
Blood, October 15, 1998; 92(8): 2963 - 2970.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. Sigal, H. Reiser, and K. L. Rock
The Role of B7-1 and B7-2 Costimulation for the Generation of CTL Responses In Vivo
J. Immunol., September 15, 1998; 161(6): 2740 - 2745.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. R. Blazar, P. A. Taylor, A. Panoskaltsis-Mortari, and D. A. Vallera
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines
J. Immunol., June 1, 1998; 160(11): 5355 - 5365.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Saito, J. Sakurai, J. Ohata, T. Kohsaka, H. Hashimoto, K. Okumura, R. Abe, and M. Azuma
Involvement of CD40 Ligand-CD40 and CTLA4-B7 Pathways in Murine Acute Graft-Versus-Host Disease Induced by Allogeneic T Cells Lacking CD28
J. Immunol., May 1, 1998; 160(9): 4225 - 4231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.